TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy.
about
Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosisPolymorphism in clinical immunology - From HLA typing to immunogenetic profilingPretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expressionAbsence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosisAnalysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impactCrosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer.TRAIL in cancer therapy: present and future challenges.Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines.MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expressionChanges in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatmentTRAIL and its receptors as targets for cancer therapy.Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells.Glycogen synthase kinase-3β regulates tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis via the NF-κB pathway in hepatocellular carcinoma.Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.Methyl jasmonate induces apoptosis and pro-apoptotic autophagy via the ROS pathway in human non-small cell lung cancerTherapeutic applications of TRAIL receptor agonists in cancer and beyond.Histone deacetylase inhibitors in lymphoma and solid malignancies.An optimized antibody-single-chain TRAIL fusion protein for cancer therapy.Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study.Death receptors as targets for anti-cancer therapy.Does aspirin-induced oxidative stress cause asthma exacerbation?Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-κB pathway to induce metastatic potential.Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL.Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent mannerTransformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.Restoration of TRAIL-induced apoptosis in a caspase-8-deficient neuroblastoma cell line by stable re-expression of caspase-8.AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.Multifunctional non-viral gene vectors with enhanced stability, improved cellular and nuclear uptake capability, and increased transfection efficiency.Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
P2860
Q24798681-BD5E3336-FE5C-450E-BE82-9AE33D2B1501Q24798836-AE032450-FF08-428A-A3E8-C8EFD38974CDQ28192323-D6064937-41B5-45AC-842E-01223D993EAEQ33213461-466BE3D0-7109-4071-B5C9-537533911A3BQ33255121-3CC4336E-620C-41F0-953F-89E90E9C7B92Q33288897-27AD04BF-A7E1-4239-8296-DD4D0160A165Q33991741-79902D4E-C8A5-4831-A444-FE09F34FAB66Q34068822-E495E586-986E-4A48-B1F0-E97E6C585E7AQ34102626-E1CDF2D8-2388-4E3F-9BF1-D84507174ECFQ34291312-99C1B780-7406-42F7-90D4-BBD4D9BE7BC7Q34468514-92520D35-2989-4900-B5CB-CF2C952CA340Q34524741-966A674B-0B7E-4FF4-8370-3965292287D4Q34708427-0CEA8B85-F879-42A3-945D-19E870CEDA93Q35927476-459ED2AC-C5A2-4707-8209-C3BACB1B37C0Q36076428-156D5706-1415-4AB2-94D8-72B8E0B98C49Q36335972-E92591D5-435C-49C7-B232-A1178A322BD0Q36739017-459122C0-D9FF-4A8C-AFA0-AA2E7DBC8FFAQ36878669-D8B39C10-23D1-48F6-9475-A96CD89CF825Q37114025-D40E481C-1446-4FC4-A78D-5CFDDC6311ACQ37118947-02B9A1A4-7E69-4B76-B7E5-A4A12C697E47Q37141627-EA8C027A-DB7F-4E48-BD3D-3860CDAE9E41Q37185605-6207E3BA-257D-4241-A24D-99E6449B97DBQ37390893-7C7771C0-E8E3-4CFB-B0C5-5C228D77C37FQ38546516-8FD2C6DC-9667-4E75-BE5B-02E1971165E1Q39205404-E4C4A419-36AC-4049-A100-8DB3C79956B5Q39249745-17F3AF9E-9173-4D4B-9AE2-A8DF42024645Q39650265-03029D19-B966-416C-A1CD-915E601BDBC4Q39682910-F192C79D-879A-46C1-B0B9-CFF0F2ADFE09Q40135330-317787F9-4092-495F-BE17-73096929820EQ40446642-137B6F1F-46A5-4526-A7AD-53CAD2298D54Q40448465-1F9796CA-5657-40F0-8E59-0DB01F952052Q40508879-88F61E10-0540-45E5-A4CD-A6C277C87FD2Q40565103-15FCA06D-BC9C-4A44-90A4-820B9F42E45DQ40576258-ABA7FE71-D1AB-4D36-8216-FD48D5A61D16Q40582634-47608CFC-7D88-476A-9C0B-E5DC1CD8F37DQ40603990-0967B7A6-E11E-407A-B7ED-5A596067431DQ42204734-58E87452-ED64-4C2D-A1B4-760D70465E7DQ44611172-12F530B1-7BB2-4E1B-BDC1-B0043C4894E6Q46769764-502FB23C-32C6-4856-8554-38B33D1A229CQ48531636-B33477C8-FB48-481E-9EBE-03EFED126018
P2860
TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@ast
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@en
TNF-related apoptosis inducing ligand
@nl
type
label
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@ast
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@en
TNF-related apoptosis inducing ligand
@nl
prefLabel
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@ast
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@en
TNF-related apoptosis inducing ligand
@nl
P2093
P356
P1433
P1476
TNF-related apoptosis inducing ...... rveillance and cancer therapy.
@en
P2093
Pfizenmaier K
Scheurich P
P2888
P304
P356
10.1023/A:1020039225764
P577
2002-10-01T00:00:00Z
P6179
1039541846